The involvement of P2X 1 receptor in pyramidal cell degeneration in the rat hippocampus after trimethyltin administration

Neuroscience Research

Volumn 71, Issue 4, 2011, Pages 396-404

  Shirakawa, Takafumi ^a,b   Nakano, Kenji ^a   Hachiya, Naomi ^b   Kato, Nobumasa ^c   Kaneko, Kiyotoshi ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA1; COX 2; Hippocampus; Neuronal cell death; P2 receptors; Trimethyltin

Indexed keywords

CYCLOOXYGENASE 2; NF 449; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; TRIMETHYLTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DEGENERATION; CELL SPECIFICITY; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIMETHYLTIN COMPOUNDS;

EID: 81055157826     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.08.005     Document Type: Article

References (55)

1. Abbracchio M.P., Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors?. Pharmacol. Ther. 1994, 64(3):445-475.
2. Abdullah L., Ait-Ghezala G., Crawford F., Crowell T.A., Barker W.W., Duara R., et al. The cyclooxygenase 2-765C promoter allele is a protective factor for Alzheimer's disease. Neurosci. Lett. 2006, 395(3):240-243.
3. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., et al. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 2002, 42(4):489-501.
4. Barnard E.A., Burnstock G., Webb T.E. G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 1994, 15(3):67-70.
5. Brambilla R., Abbracchio M.P. Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. N. Y. Acad. Sci. 2001, 939:54-62.
6. Brambilla R., Ceruti S., Malorni W., Cattabeni F., Abbracchio M.P. A novel gliotic P2 receptor mediating cyclooxygenase-2 induction in rat and human astrocytes. J. Auton. Nerv. Syst. 2000, 81(1-3):3-9.
7. Braun K., Rettinger J., Ganso M., Kassack M., Hildebrandt C., Ullmann H., et al. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn. Schmiedebergs Arch. Pharmacol. 2001, 364(3):285-290.
8. Cavaliere F., Amadio S., Dinkel K., Reymann K.G., Volonte C. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death. J. Pharmacol. Exp. Ther. 2007, 323(1):70-77.
9. Cavaliere F., D'Ambrosi N., Ciotti M.T., Mancino G., Sancesario G., Bernardi G., et al. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem. Int. 2001, 38(3):189-197.
10. Cavaliere F., Dinkel K., Reymann K. Microglia response and P2 receptor participation in oxygen/glucose deprivation-induced cortical damage. Neuroscience 2005, 136(3):615-623.
11. Cavaliere F., Florenzano F., Amadio S., Fusco F.R., Viscomi M.T., D'Ambrosi N., et al. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 2003, 120(1):85-98.
12. Cham J.L., Owens N.C., Barden J.A., Lawrence A.J., Badoer E. P2X purinoceptor subtypes on paraventricular nucleus neurones projecting to the rostral ventrolateral medulla in the rat. Exp. Physiol. 2006, 91(2):403-411.
13. Chang L.W., Dyer R.S. A time-course study of trimethyltin induced neuropathology in rats. Neurobehav. Toxicol. Teratol. 1983, 5(4):443-459.
14. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003, 62(2):127-136.
15. Dyer R.S., Deshields T.L., Wonderlin W.F. Trimethyltin-induced changes in gross morphology of the hippocampus. Neurobehav. Toxicol. Teratol. 1982, 4(2):141-147.
16. Ferrero M.E. A new approach to the inflammatory/autoimmune diseases. Recent Pat. Antiinfect. Drug Discov. 2009, 4(2):108-113.
17. Franke H., Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 2006, 109(3):297-324.
18. Govoni S., Masoero E., Favalli L., Rozza A., Scelsi R., Viappiani S., et al. The cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci. Lett. 2001, 303(2):91-94.
19. Honda S., Sasaki Y., Ohsawa K., Imai Y., Nakamura Y., Inoue K., et al. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 2001, 21(6):1975-1982.
20. Ikeda M., Kanai H., Akaike M., Tsutsumi S., Sadamatsu M., Masui A., et al. Nitric oxide synthase-containing neurons in the hippocampus are preserved in trimethyltin intoxication. Brain Res. 1996, 712(1):168-170.
21. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., et al. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 1997, 81(4):1183-1191.
22. Kassack M.U., Braun K., Ganso M., Ullmann H., Nickel P., Boing B., et al. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist. Eur. J. Med. Chem. 2004, 39(4):345-357.
23. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 2006, 12(2):225-229.
24. Kharlamov A., Jones S.C., Kim D.K. Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp. Brain Res. 2002, 147(3):353-359.
25. Kim D.S., Kwak S.E., Kim J.E., Won M.H., Kang T.C. The co-treatments of vigabatrin and P2X receptor antagonists protect ischemic neuronal cell death in the gerbil hippocampus. Brain Res. 2006, 1120(1):151-160.
26. Kittner H., Franke H., Fischer W., Schultheis N., Krugel U., Illes P. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology 2003, 28(3):435-444.
27. Koistinaho J., Koponen S., Chan P.H. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke 1999, 30(9):1900-1905. (discussion 1905-1906).
28. Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446(7139):1091-1095.
29. Kunz T., Marklund N., Hillered L., Oliw E.H. Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat. Restor. Neurol. Neurosci. 2006, 24(1):55-63.
30. Latini L., Geloso M.C., Corvino V., Giannetti S., Florenzano F., Viscomi M.T., et al. Trimethyltin intoxication up-regulates nitric oxide synthase in neurons and purinergic ionotropic receptor 2 in astrocytes in the hippocampus. J. Neurosci. Res. 2010, 88(3):500-509.
31. Liang X., Wu L., Wang Q., Hand T., Bilak M., McCullough L., et al. Function of COX-2 and prostaglandins in neurological disease. J. Mol. Neurosci. 2007, 33(1):94-99.
32. Liu M., Sun A., Shin E.J., Liu X., Kim S.G., Runyons C.R., et al. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur. J. Neurosci. 2006, 23(8):2027-2034.
33. Liu Y., Imai H., Sadamatsu M., Tsunashima K., Kato N. Cytokines participate in neuronal death induced by trimethyltin in the rat hippocampus via type II glucocorticoid receptors. Neurosci. Res. 2005, 51(3):319-327.
34. 2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res. 2005, 81(3):349-356.
35. Moran-Jimenez M.J., Matute C. Immunohistochemical localization of the P2Y(1) purinergic receptor in neurons and glial cells of the central nervous system. Brain Res. Mol. Brain Res. 2000, 78(1-2):50-58.
36. Morita M., Imai H., Liu Y., Xu X., Sadamatsu M., Nakagami R., et al. FK506-protective effects against trimethyltin neurotoxicity in rats: hippocampal expression analyses reveal the involvement of periarterial osteopontin. Neuroscience 2008, 153(4):1135-1145.
37. Nilsberth C., Kostyszyn B., Luthman J. Changes in APP, PS1 and other factors related to Alzheimer's disease pathophysiology after trimethyltin-induced brain lesion in the rat. Neurotox. Res. 2002, 4(7-8):625-636.
38. Nishimura T., Schwarzer C., Furtinger S., Imai H., Kato N., Sperk G. Changes in the GABA-ergic system induced by trimethyltin application in the rat. Brain Res. Mol. Brain Res. 2001, 97(1):1-6.
39. North R.A., Barnard E.A. Nucleotide receptors. Curr. Opin. Neurobiol. 1997, 7(3):346-357.
40. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 2003, 278(15):13309-13317.
41. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50(3):413-492.
42. Rettinger J., Braun K., Hochmann H., Kassack M.U., Ullmann H., Nickel P., et al. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 2005, 48(3):461-468.
43. Ruppert P.H., Walsh T.J., Reiter L.W., Dyer R.S. Trimethyltin-induced hyperactivity: time course and pattern. Neurobehav. Toxicol. Teratol. 1982, 4(2):135-139.
44. Shirakawa T., Nakano K., Hachiya N.S., Kato N., Kaneko K. Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration. Neurosci. Res. 2007, 59(2):117-123.
45. Swanson L.W. Brain Maps: Structure of the Rat Brain 1992, Elsevier Science Publishers BV.
46. Takemiya T., Maehara M., Matsumura K., Yasuda S., Sugiura H., Yamagata K. Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neurosci. Res. 2006, 56(1):103-110.
47. Tsunashima K., Sadamatsu M., Takahashi Y., Kato N., Sperk G. Trimethyltin intoxication induces marked changes in neuropeptide expression in the rat hippocampus. Synapse 1998, 29(4):333-342.
48. Tsutsumi S., Akaike M., Arimitsu H., Imai H., Kato N. Circulating corticosterone alters the rate of neuropathological and behavioral changes induced by trimethyltin in rats. Exp. Neurol. 2002, 173(1):86-94.
49. Volonte C., Amadio S., Cavaliere F., D'Ambrosi N., Vacca F., Bernardi G. Extracellular ATP and neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2003, 2(6):403-412.
50. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 2006, 110(3):415-432.
51. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184(1-2):53-68.
52. Woofruff M.L. Trimethyltin neurotoxicity in the rat as an analogous model of Alzheimer's disease. Toxin-induced Models of Neurological Disorders 1994, 319-335. Plenum Press, New York. M.L. Woodruff, A.J. Nonneman (Eds.).
53. Xiang Z., He C., Burnstock G. P2X5 receptors are expressed on neurons containing arginine vasopressin and nitric oxide synthase in the rat hypothalamus. Brain Res. 2006, 1099(1):56-63.
54. Xu J., Chalimoniuk M., Shu Y., Simonyi A., Sun A.Y., Gonzalez F.A., et al. Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69(6):437-448.
55. Zhang Z., Artelt M., Burnet M., Trautmann K., Schluesener H.J. Early infiltration of CD8+ macrophages/microglia to lesions of rat traumatic brain injury. Neuroscience 2006, 141(2):637-644.